

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.74628390 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.72680696 |
| 3 | vocalization behavior (GO:0071625) | 5.54879117 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.40546194 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.36606249 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.27051186 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.08287734 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.07797521 |
| 9 | glutamate secretion (GO:0014047) | 4.96974821 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.86380222 |
| 11 | protein localization to synapse (GO:0035418) | 4.77134843 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 4.69166394 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.66153786 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.64490187 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.64114100 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.63571649 |
| 17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.56676922 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.48602603 |
| 19 | * positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.46806028 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.39137354 |
| 21 | exploration behavior (GO:0035640) | 4.38236573 |
| 22 | * glutamate receptor signaling pathway (GO:0007215) | 4.35019043 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.30507559 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 4.29905724 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.27898461 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.18641799 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.16710180 |
| 28 | sodium ion export (GO:0071436) | 4.13592839 |
| 29 | L-amino acid import (GO:0043092) | 4.06490137 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03227985 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.94037498 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.92478731 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 3.90099133 |
| 34 | long-term memory (GO:0007616) | 3.87302551 |
| 35 | positive regulation of membrane potential (GO:0045838) | 3.85434059 |
| 36 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.81301165 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81123971 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.78499620 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.77649887 |
| 40 | neuron recognition (GO:0008038) | 3.75103577 |
| 41 | regulation of synaptic plasticity (GO:0048167) | 3.73054608 |
| 42 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.72158690 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.72131527 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.70507439 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.68307282 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.67849397 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.67657140 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.66492465 |
| 49 | cellular sodium ion homeostasis (GO:0006883) | 3.62068809 |
| 50 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.56782900 |
| 51 | axon ensheathment in central nervous system (GO:0032291) | 3.55824836 |
| 52 | central nervous system myelination (GO:0022010) | 3.55824836 |
| 53 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.55513202 |
| 54 | cerebellar granule cell differentiation (GO:0021707) | 3.54076680 |
| 55 | response to histamine (GO:0034776) | 3.52976898 |
| 56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.52810597 |
| 57 | postsynaptic membrane organization (GO:0001941) | 3.51289425 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.48337044 |
| 59 | auditory behavior (GO:0031223) | 3.40646590 |
| 60 | positive regulation of neurotransmitter transport (GO:0051590) | 3.40588927 |
| 61 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.39586695 |
| 62 | axonal fasciculation (GO:0007413) | 3.39042220 |
| 63 | amino acid import (GO:0043090) | 3.38058782 |
| 64 | potassium ion import (GO:0010107) | 3.35594739 |
| 65 | regulation of dendritic spine development (GO:0060998) | 3.35176924 |
| 66 | behavioral defense response (GO:0002209) | 3.35078666 |
| 67 | behavioral fear response (GO:0001662) | 3.35078666 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.34916606 |
| 69 | neurotransmitter transport (GO:0006836) | 3.33402203 |
| 70 | behavioral response to cocaine (GO:0048148) | 3.33370311 |
| 71 | proline transport (GO:0015824) | 3.33183042 |
| 72 | cellular potassium ion homeostasis (GO:0030007) | 3.30558520 |
| 73 | prepulse inhibition (GO:0060134) | 3.30399365 |
| 74 | activation of protein kinase A activity (GO:0034199) | 3.26435751 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.25866554 |
| 76 | regulation of vesicle fusion (GO:0031338) | 3.25856999 |
| 77 | C4-dicarboxylate transport (GO:0015740) | 3.24268798 |
| 78 | neuromuscular process controlling balance (GO:0050885) | 3.23314745 |
| 79 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22810767 |
| 80 | synaptic vesicle endocytosis (GO:0048488) | 3.21249493 |
| 81 | membrane depolarization (GO:0051899) | 3.19857825 |
| 82 | response to auditory stimulus (GO:0010996) | 3.19765294 |
| 83 | serotonin metabolic process (GO:0042428) | 3.18976569 |
| 84 | striatum development (GO:0021756) | 3.15658503 |
| 85 | regulation of neurotransmitter levels (GO:0001505) | 3.15585710 |
| 86 | learning (GO:0007612) | 3.15401398 |
| 87 | long term synaptic depression (GO:0060292) | 3.15210965 |
| 88 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.14577662 |
| 89 | cell communication by electrical coupling (GO:0010644) | 3.14125605 |
| 90 | detection of calcium ion (GO:0005513) | 3.13463846 |
| 91 | potassium ion homeostasis (GO:0055075) | 3.13273676 |
| 92 | fear response (GO:0042596) | 3.13132971 |
| 93 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12341754 |
| 94 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.11121404 |
| 95 | regulation of glutamate secretion (GO:0014048) | 3.08913810 |
| 96 | regulation of neurotransmitter transport (GO:0051588) | 3.08265849 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 3.08061174 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.07952156 |
| 99 | dendritic spine organization (GO:0097061) | 3.07783756 |
| 100 | startle response (GO:0001964) | 3.07687903 |
| 101 | synaptic transmission, dopaminergic (GO:0001963) | 3.03198599 |
| 102 | synapse assembly (GO:0007416) | 3.02498943 |
| 103 | regulation of female receptivity (GO:0045924) | 3.02303508 |
| 104 | membrane hyperpolarization (GO:0060081) | 3.00595926 |
| 105 | dendrite morphogenesis (GO:0048813) | 3.00447703 |
| 106 | regulation of synaptic transmission (GO:0050804) | 3.00108680 |
| 107 | negative regulation of dendrite development (GO:2000171) | 2.98246909 |
| 108 | membrane depolarization during action potential (GO:0086010) | 2.96511564 |
| 109 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95941937 |
| 110 | * synaptic transmission (GO:0007268) | 2.95694709 |
| 111 | primary amino compound metabolic process (GO:1901160) | 2.95067645 |
| 112 | regulation of synapse maturation (GO:0090128) | 2.94727938 |
| 113 | cell communication involved in cardiac conduction (GO:0086065) | 2.94620674 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.94383998 |
| 115 | mechanosensory behavior (GO:0007638) | 2.93960030 |
| 116 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91719816 |
| 117 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.91269845 |
| 118 | innervation (GO:0060384) | 2.91235427 |
| 119 | neuronal ion channel clustering (GO:0045161) | 2.89581805 |
| 120 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.88547259 |
| 121 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.87560628 |
| 122 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.86746919 |
| 123 | neurotransmitter uptake (GO:0001504) | 2.85153129 |
| 124 | cochlea development (GO:0090102) | 2.81345838 |
| 125 | neuromuscular synaptic transmission (GO:0007274) | 2.75616270 |
| 126 | regulation of dendrite morphogenesis (GO:0048814) | 2.74507096 |
| 127 | adult walking behavior (GO:0007628) | 2.70429791 |
| 128 | positive regulation of dendrite development (GO:1900006) | 2.69873719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.92984559 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.03447739 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15512958 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07769614 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06010783 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67968470 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67968470 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65974688 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59168255 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.53229123 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53013887 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52501936 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50360257 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49705398 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46016984 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40738315 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35255440 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32113146 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14611916 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13168077 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09996454 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.02559470 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99922243 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.99206371 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94880742 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94050185 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92253052 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89558592 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83570153 |
| 30 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77411528 |
| 31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77076995 |
| 32 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68646016 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.68266053 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67101237 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66375924 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65477448 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59181502 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58114235 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48626064 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45386981 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45291478 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43735279 |
| 43 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43616280 |
| 44 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42844201 |
| 45 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.42427737 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39150616 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37885692 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37012049 |
| 49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.36093498 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36010345 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33643237 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32187001 |
| 53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31643733 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30234672 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29617653 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29269703 |
| 57 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28998200 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26437012 |
| 59 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25326582 |
| 60 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23148559 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23105160 |
| 62 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22271974 |
| 63 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22214745 |
| 64 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22177141 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19823829 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19675104 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19638856 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18309163 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.18157762 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17731318 |
| 71 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16649443 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15853241 |
| 73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14463512 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14027684 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13582612 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12414096 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12014217 |
| 78 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11758660 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11188162 |
| 80 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10872676 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10819304 |
| 82 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09695561 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07946400 |
| 84 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.07453826 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07420635 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07417193 |
| 87 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07275542 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06844264 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06699535 |
| 90 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06577724 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06573469 |
| 92 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06568436 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05096339 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04741168 |
| 95 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04223977 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03917239 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03467194 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02822736 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02530963 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01219447 |
| 101 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00940785 |
| 102 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00093509 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00093509 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99329993 |
| 105 | JUN_21703547_ChIP-Seq_K562_Human | 0.97820445 |
| 106 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95620321 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94848737 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94669624 |
| 109 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94564187 |
| 110 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94176299 |
| 111 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93560951 |
| 112 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92957313 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92468085 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91356080 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91223464 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91093950 |
| 117 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90746779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.64051246 |
| 2 | MP0003880_abnormal_central_pattern | 5.13155602 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.27902877 |
| 4 | MP0004270_analgesia | 3.72714693 |
| 5 | MP0002822_catalepsy | 3.59771982 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.58874401 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.52979383 |
| 8 | * MP0002064_seizures | 3.15792697 |
| 9 | MP0009046_muscle_twitch | 3.03907930 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.02565536 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.97711638 |
| 12 | * MP0001486_abnormal_startle_reflex | 2.63389063 |
| 13 | MP0002272_abnormal_nervous_system | 2.59810751 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.48504795 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.43688786 |
| 16 | MP0002736_abnormal_nociception_after | 2.39005104 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.34444740 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.22689348 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.09487135 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.07530799 |
| 21 | MP0002067_abnormal_sensory_capabilities | 1.93741232 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.92375217 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.88822311 |
| 24 | MP0001970_abnormal_pain_threshold | 1.86219315 |
| 25 | MP0004924_abnormal_behavior | 1.84214123 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.84214123 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.79345777 |
| 28 | MP0003329_amyloid_beta_deposits | 1.78932693 |
| 29 | MP0000778_abnormal_nervous_system | 1.76734745 |
| 30 | MP0001529_abnormal_vocalization | 1.75410260 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.72527036 |
| 32 | MP0002184_abnormal_innervation | 1.70059122 |
| 33 | MP0001984_abnormal_olfaction | 1.67244097 |
| 34 | MP0003879_abnormal_hair_cell | 1.65077867 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.62070387 |
| 36 | * MP0008569_lethality_at_weaning | 1.57099573 |
| 37 | MP0001188_hyperpigmentation | 1.48743853 |
| 38 | MP0004858_abnormal_nervous_system | 1.46460674 |
| 39 | MP0003123_paternal_imprinting | 1.44446371 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.41532116 |
| 41 | MP0000955_abnormal_spinal_cord | 1.40156316 |
| 42 | * MP0002066_abnormal_motor_capabilities/c | 1.37242593 |
| 43 | MP0003633_abnormal_nervous_system | 1.34853612 |
| 44 | MP0003787_abnormal_imprinting | 1.33933451 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.31535724 |
| 46 | MP0001905_abnormal_dopamine_level | 1.31195888 |
| 47 | MP0003195_calcinosis | 1.28515732 |
| 48 | MP0003121_genomic_imprinting | 1.27170528 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.25016014 |
| 50 | MP0004885_abnormal_endolymph | 1.23658101 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.19079835 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.14333665 |
| 53 | MP0003631_nervous_system_phenotype | 1.12520884 |
| 54 | MP0005409_darkened_coat_color | 1.12059192 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.10485844 |
| 56 | MP0004142_abnormal_muscle_tone | 1.08471943 |
| 57 | MP0008872_abnormal_physiological_respon | 1.07301938 |
| 58 | MP0008874_decreased_physiological_sensi | 1.04438813 |
| 59 | * MP0002152_abnormal_brain_morphology | 1.03846422 |
| 60 | MP0000013_abnormal_adipose_tissue | 0.98214187 |
| 61 | MP0000566_synostosis | 0.97910331 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.95119028 |
| 63 | MP0001177_atelectasis | 0.94825103 |
| 64 | MP0004085_abnormal_heartbeat | 0.93052956 |
| 65 | MP0000751_myopathy | 0.91855189 |
| 66 | MP0005535_abnormal_body_temperature | 0.91101168 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.89496475 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.89458232 |
| 69 | MP0003868_abnormal_feces_composition | 0.88735690 |
| 70 | MP0003690_abnormal_glial_cell | 0.88660301 |
| 71 | MP0003075_altered_response_to | 0.88068131 |
| 72 | MP0004484_altered_response_of | 0.84654801 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.83894723 |
| 74 | MP0004742_abnormal_vestibular_system | 0.83681475 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.82500957 |
| 76 | MP0002229_neurodegeneration | 0.81318256 |
| 77 | MP0005187_abnormal_penis_morphology | 0.81291402 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.78800956 |
| 79 | MP0003122_maternal_imprinting | 0.78443137 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.78404058 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.78097401 |
| 82 | MP0000604_amyloidosis | 0.77595675 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.77303691 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.75076557 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 0.74570721 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.71333045 |
| 87 | MP0003632_abnormal_nervous_system | 0.71260215 |
| 88 | MP0003634_abnormal_glial_cell | 0.70962504 |
| 89 | MP0005499_abnormal_olfactory_system | 0.69334499 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.69334499 |
| 91 | MP0005171_absent_coat_pigmentation | 0.68521436 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.68444095 |
| 93 | MP0001664_abnormal_digestion | 0.68055078 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.66492421 |
| 95 | MP0002090_abnormal_vision | 0.65901281 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.65336505 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.65308455 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.65048546 |
| 99 | MP0000920_abnormal_myelination | 0.62505470 |
| 100 | MP0001346_abnormal_lacrimal_gland | 0.60495850 |
| 101 | MP0004233_abnormal_muscle_weight | 0.60369725 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.60146167 |
| 103 | MP0004147_increased_porphyrin_level | 0.60045151 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.59640356 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.57825929 |
| 106 | * MP0002082_postnatal_lethality | 0.54876947 |
| 107 | * MP0010770_preweaning_lethality | 0.54876947 |
| 108 | * MP0010769_abnormal_survival | 0.53627319 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.52740049 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.52326291 |
| 111 | MP0001943_abnormal_respiration | 0.52309265 |
| 112 | MP0004043_abnormal_pH_regulation | 0.50171583 |
| 113 | MP0004134_abnormal_chest_morphology | 0.50046559 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.49738556 |
| 115 | * MP0010768_mortality/aging | 0.49588203 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.49403374 |
| 117 | MP0004130_abnormal_muscle_cell | 0.48864133 |
| 118 | MP0003283_abnormal_digestive_organ | 0.48614265 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.46857255 |
| 120 | MP0005620_abnormal_muscle_contractility | 0.46851970 |
| 121 | MP0003861_abnormal_nervous_system | 0.46772370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.64672599 |
| 2 | Myokymia (HP:0002411) | 6.90763871 |
| 3 | * Focal seizures (HP:0007359) | 5.71144652 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.51684356 |
| 5 | Atonic seizures (HP:0010819) | 4.96436865 |
| 6 | Visual hallucinations (HP:0002367) | 4.95794167 |
| 7 | Febrile seizures (HP:0002373) | 4.82364189 |
| 8 | Hyperventilation (HP:0002883) | 4.51702198 |
| 9 | Absence seizures (HP:0002121) | 4.32549842 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.21504265 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.06613908 |
| 12 | Dialeptic seizures (HP:0011146) | 4.02149788 |
| 13 | Broad-based gait (HP:0002136) | 3.97117371 |
| 14 | Poor eye contact (HP:0000817) | 3.80195238 |
| 15 | Action tremor (HP:0002345) | 3.55655934 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.49472234 |
| 17 | Abnormal social behavior (HP:0012433) | 3.41367553 |
| 18 | Impaired social interactions (HP:0000735) | 3.41367553 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.36668685 |
| 20 | Amblyopia (HP:0000646) | 3.30563151 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.24033880 |
| 22 | Anxiety (HP:0000739) | 3.16435475 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 3.05517010 |
| 24 | Depression (HP:0000716) | 3.05448747 |
| 25 | Papillary thyroid carcinoma (HP:0002895) | 3.03837812 |
| 26 | Dysmetria (HP:0001310) | 3.03114770 |
| 27 | Truncal ataxia (HP:0002078) | 2.99811546 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.98444324 |
| 29 | Drooling (HP:0002307) | 2.96392100 |
| 30 | Excessive salivation (HP:0003781) | 2.96392100 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.94591354 |
| 32 | Ankle clonus (HP:0011448) | 2.83118709 |
| 33 | Scanning speech (HP:0002168) | 2.78471403 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.78161997 |
| 35 | Stereotypic behavior (HP:0000733) | 2.75157351 |
| 36 | Abnormality of binocular vision (HP:0011514) | 2.74665961 |
| 37 | Diplopia (HP:0000651) | 2.74665961 |
| 38 | Torticollis (HP:0000473) | 2.74141817 |
| 39 | Absent speech (HP:0001344) | 2.70296580 |
| 40 | Impaired smooth pursuit (HP:0007772) | 2.69439070 |
| 41 | Postural instability (HP:0002172) | 2.69000780 |
| 42 | Hemiparesis (HP:0001269) | 2.68451375 |
| 43 | Genetic anticipation (HP:0003743) | 2.67166023 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.60039386 |
| 45 | Focal dystonia (HP:0004373) | 2.57685378 |
| 46 | Mutism (HP:0002300) | 2.56392115 |
| 47 | Papilledema (HP:0001085) | 2.55072105 |
| 48 | Abnormality of the lower motor neuron (HP:0002366) | 2.51764020 |
| 49 | Progressive inability to walk (HP:0002505) | 2.49908148 |
| 50 | Inability to walk (HP:0002540) | 2.48609019 |
| 51 | Urinary urgency (HP:0000012) | 2.45785424 |
| 52 | Dysmetric saccades (HP:0000641) | 2.44955253 |
| 53 | Status epilepticus (HP:0002133) | 2.43845147 |
| 54 | * Epileptiform EEG discharges (HP:0011182) | 2.43329164 |
| 55 | Fetal akinesia sequence (HP:0001989) | 2.40488671 |
| 56 | Bradykinesia (HP:0002067) | 2.39696153 |
| 57 | Termporal pattern (HP:0011008) | 2.38034668 |
| 58 | Insidious onset (HP:0003587) | 2.38034668 |
| 59 | Impaired vibratory sensation (HP:0002495) | 2.36709060 |
| 60 | Alacrima (HP:0000522) | 2.31434933 |
| 61 | Blue irides (HP:0000635) | 2.31258034 |
| 62 | Craniofacial dystonia (HP:0012179) | 2.28403628 |
| 63 | Spastic gait (HP:0002064) | 2.25305893 |
| 64 | Increased circulating renin level (HP:0000848) | 2.24798950 |
| 65 | Generalized myoclonic seizures (HP:0002123) | 2.23771677 |
| 66 | Hepatoblastoma (HP:0002884) | 2.23659315 |
| 67 | Protruding tongue (HP:0010808) | 2.23083468 |
| 68 | Annular pancreas (HP:0001734) | 2.22224211 |
| 69 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.21744168 |
| 70 | * EEG with generalized epileptiform discharges (HP:0011198) | 2.21502392 |
| 71 | Polyphagia (HP:0002591) | 2.20711727 |
| 72 | Hemiplegia (HP:0002301) | 2.20181561 |
| 73 | Intention tremor (HP:0002080) | 2.16561271 |
| 74 | Tetraplegia (HP:0002445) | 2.15729671 |
| 75 | Resting tremor (HP:0002322) | 2.11686188 |
| 76 | Incomplete penetrance (HP:0003829) | 2.11143170 |
| 77 | Akinesia (HP:0002304) | 2.10773174 |
| 78 | Limb dystonia (HP:0002451) | 2.07358717 |
| 79 | Megalencephaly (HP:0001355) | 2.07247235 |
| 80 | Abnormality of salivation (HP:0100755) | 2.02461516 |
| 81 | * Hypsarrhythmia (HP:0002521) | 2.02313797 |
| 82 | Abnormality of the corticospinal tract (HP:0002492) | 2.00913168 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.00865088 |
| 84 | Generalized hypopigmentation of hair (HP:0011358) | 2.00513053 |
| 85 | Epidermoid cyst (HP:0200040) | 1.94990418 |
| 86 | Fair hair (HP:0002286) | 1.94248858 |
| 87 | Gait imbalance (HP:0002141) | 1.93788129 |
| 88 | Heterotopia (HP:0002282) | 1.93719162 |
| 89 | Decreased lacrimation (HP:0000633) | 1.93638614 |
| 90 | Lower limb amyotrophy (HP:0007210) | 1.93349105 |
| 91 | Gait ataxia (HP:0002066) | 1.93170118 |
| 92 | Pheochromocytoma (HP:0002666) | 1.90435533 |
| 93 | Delusions (HP:0000746) | 1.86648490 |
| 94 | Lower limb asymmetry (HP:0100559) | 1.84381883 |
| 95 | Thickened helices (HP:0000391) | 1.83080210 |
| 96 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78054993 |
| 97 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78054993 |
| 98 | Aplasia involving bones of the extremities (HP:0009825) | 1.77942254 |
| 99 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77942254 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77942254 |
| 101 | Widely spaced teeth (HP:0000687) | 1.77531018 |
| 102 | Pointed chin (HP:0000307) | 1.77306680 |
| 103 | Exotropia (HP:0000577) | 1.77301908 |
| 104 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75853277 |
| 105 | Specific learning disability (HP:0001328) | 1.75765441 |
| 106 | Oligodactyly (hands) (HP:0001180) | 1.75710282 |
| 107 | Clonus (HP:0002169) | 1.74850709 |
| 108 | Abnormal EKG (HP:0003115) | 1.74062630 |
| 109 | Inappropriate behavior (HP:0000719) | 1.73789786 |
| 110 | Obstructive sleep apnea (HP:0002870) | 1.72192929 |
| 111 | Ankyloglossia (HP:0010296) | 1.71987485 |
| 112 | Bundle branch block (HP:0011710) | 1.71429639 |
| 113 | Intestinal atresia (HP:0011100) | 1.70601789 |
| 114 | Psychosis (HP:0000709) | 1.69917958 |
| 115 | Deeply set eye (HP:0000490) | 1.69110720 |
| 116 | Hyperthyroidism (HP:0000836) | 1.68467286 |
| 117 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.67774747 |
| 118 | Deep venous thrombosis (HP:0002625) | 1.66943444 |
| 119 | Spastic tetraparesis (HP:0001285) | 1.65185866 |
| 120 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.60611307 |
| 121 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.60593354 |
| 122 | Volvulus (HP:0002580) | 1.60157653 |
| 123 | Sleep apnea (HP:0010535) | 1.58902454 |
| 124 | Thyroid carcinoma (HP:0002890) | 1.57543735 |
| 125 | Spastic tetraplegia (HP:0002510) | 1.57303928 |
| 126 | Cerebral hypomyelination (HP:0006808) | 1.55859904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.52213875 |
| 2 | NTRK3 | 4.45786913 |
| 3 | MAP3K9 | 3.39316067 |
| 4 | MAP3K4 | 2.87047093 |
| 5 | MARK1 | 2.79986531 |
| 6 | RIPK4 | 2.74302351 |
| 7 | CASK | 2.60569950 |
| 8 | DAPK2 | 2.58201849 |
| 9 | MAP2K7 | 2.54481394 |
| 10 | MINK1 | 2.46600618 |
| 11 | FRK | 2.22706846 |
| 12 | KSR2 | 2.06307514 |
| 13 | PAK6 | 1.94820723 |
| 14 | NTRK2 | 1.94397168 |
| 15 | MAP2K4 | 1.84026974 |
| 16 | KSR1 | 1.83101574 |
| 17 | MAP3K12 | 1.77100117 |
| 18 | DAPK1 | 1.71666928 |
| 19 | PRKD3 | 1.70963354 |
| 20 | TNIK | 1.69554135 |
| 21 | NTRK1 | 1.68654982 |
| 22 | CAMKK1 | 1.68306340 |
| 23 | PLK2 | 1.65935362 |
| 24 | CDK5 | 1.51986038 |
| 25 | PIK3CA | 1.51626504 |
| 26 | FES | 1.45487632 |
| 27 | MAPK13 | 1.41181848 |
| 28 | ARAF | 1.39970490 |
| 29 | SIK2 | 1.36994447 |
| 30 | MAP3K13 | 1.36914025 |
| 31 | BMPR2 | 1.36274410 |
| 32 | STK39 | 1.34335177 |
| 33 | PRPF4B | 1.33088478 |
| 34 | GRK5 | 1.29751798 |
| 35 | CDK19 | 1.26217992 |
| 36 | PRKCG | 1.22520110 |
| 37 | PNCK | 1.21041397 |
| 38 | CAMKK2 | 1.14897623 |
| 39 | PTK2B | 1.12562901 |
| 40 | CAMK2A | 1.08588339 |
| 41 | MAP3K2 | 1.06605125 |
| 42 | STK38 | 1.02566101 |
| 43 | RAF1 | 1.01934057 |
| 44 | TYRO3 | 0.95274001 |
| 45 | SGK223 | 0.94049886 |
| 46 | SGK494 | 0.94049886 |
| 47 | WNK4 | 0.93107937 |
| 48 | WNK1 | 0.92545331 |
| 49 | SGK2 | 0.91365180 |
| 50 | BMPR1B | 0.88622282 |
| 51 | CCNB1 | 0.87603149 |
| 52 | CAMK2B | 0.87433790 |
| 53 | CAMK1 | 0.85180275 |
| 54 | OXSR1 | 0.83129252 |
| 55 | CDK18 | 0.79972244 |
| 56 | STK11 | 0.79969653 |
| 57 | OBSCN | 0.78498107 |
| 58 | UHMK1 | 0.76161499 |
| 59 | SGK1 | 0.75965764 |
| 60 | ACVR1B | 0.75943509 |
| 61 | CDK15 | 0.75602974 |
| 62 | PKN1 | 0.74891127 |
| 63 | PHKG1 | 0.74763001 |
| 64 | PHKG2 | 0.74763001 |
| 65 | TAOK1 | 0.74681664 |
| 66 | CDK14 | 0.74585115 |
| 67 | LATS2 | 0.74252102 |
| 68 | RET | 0.68552660 |
| 69 | PINK1 | 0.68330206 |
| 70 | SGK3 | 0.67264644 |
| 71 | DYRK1A | 0.66579351 |
| 72 | AKT3 | 0.66477998 |
| 73 | PRKCE | 0.66412231 |
| 74 | FGR | 0.66372625 |
| 75 | FGFR3 | 0.65716592 |
| 76 | CSNK1A1L | 0.64976811 |
| 77 | SIK3 | 0.64532676 |
| 78 | CDK11A | 0.63586685 |
| 79 | PRKCH | 0.62713773 |
| 80 | RIPK1 | 0.62531376 |
| 81 | CSNK1G1 | 0.62165608 |
| 82 | CSNK1D | 0.61918019 |
| 83 | PDPK1 | 0.61351060 |
| 84 | PAK3 | 0.60605952 |
| 85 | MARK2 | 0.60148137 |
| 86 | PDK1 | 0.60016679 |
| 87 | CSNK1E | 0.59565131 |
| 88 | MAP3K6 | 0.57779594 |
| 89 | PRKG1 | 0.55425785 |
| 90 | LMTK2 | 0.52183284 |
| 91 | CSNK1G2 | 0.51727620 |
| 92 | INSRR | 0.51533519 |
| 93 | DMPK | 0.51530538 |
| 94 | MAP3K7 | 0.50048205 |
| 95 | PRKCZ | 0.49482537 |
| 96 | NME1 | 0.49011017 |
| 97 | NEK6 | 0.48208814 |
| 98 | FER | 0.47205933 |
| 99 | RPS6KA3 | 0.46773200 |
| 100 | CDK3 | 0.46235804 |
| 101 | MUSK | 0.46014969 |
| 102 | MAP3K1 | 0.45821795 |
| 103 | ERBB2 | 0.45221720 |
| 104 | CAMK2D | 0.44904201 |
| 105 | CAMK2G | 0.44104488 |
| 106 | FYN | 0.43502699 |
| 107 | MAPK12 | 0.42832315 |
| 108 | RPS6KB1 | 0.42431189 |
| 109 | PRKAA1 | 0.42091078 |
| 110 | BCR | 0.41732690 |
| 111 | CSNK1G3 | 0.40226250 |
| 112 | ROCK1 | 0.39559382 |
| 113 | CAMK1G | 0.39257474 |
| 114 | FGFR1 | 0.38874383 |
| 115 | TNK2 | 0.38810076 |
| 116 | CAMK4 | 0.38680691 |
| 117 | BRAF | 0.36553026 |
| 118 | MAPK10 | 0.35962949 |
| 119 | WNK3 | 0.35936772 |
| 120 | FGFR2 | 0.35422946 |
| 121 | DAPK3 | 0.34149179 |
| 122 | ADRBK2 | 0.32193157 |
| 123 | PRKCB | 0.31613013 |
| 124 | PRKACA | 0.31330172 |
| 125 | CDC42BPA | 0.30935426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.82426965 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.08582597 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.85354411 |
| 4 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.76555143 |
| 5 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.75128020 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73735144 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72084459 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.68282628 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68140329 |
| 10 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64043182 |
| 11 | * Salivary secretion_Homo sapiens_hsa04970 | 2.22832957 |
| 12 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20044832 |
| 13 | * Insulin secretion_Homo sapiens_hsa04911 | 1.92227331 |
| 14 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.89248292 |
| 15 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87305107 |
| 16 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85374646 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.83587047 |
| 18 | * Renin secretion_Homo sapiens_hsa04924 | 1.83131685 |
| 19 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.78626365 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.75259184 |
| 21 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73387094 |
| 22 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71440524 |
| 23 | * Long-term depression_Homo sapiens_hsa04730 | 1.69093097 |
| 24 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.66763231 |
| 25 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55338395 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53953199 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38491265 |
| 28 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36414256 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35117672 |
| 30 | * Gap junction_Homo sapiens_hsa04540 | 1.31340957 |
| 31 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20430851 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17987004 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16442869 |
| 34 | Axon guidance_Homo sapiens_hsa04360 | 1.15470396 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.14861291 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14506670 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10344273 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09769397 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08765777 |
| 40 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07508803 |
| 41 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05791414 |
| 42 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02680047 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99719071 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99253811 |
| 45 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96722800 |
| 46 | * Melanogenesis_Homo sapiens_hsa04916 | 0.94929579 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88404212 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86350996 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86156753 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.82962962 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82707818 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82285138 |
| 53 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.81045450 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80908834 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80144974 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77601898 |
| 57 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76647381 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75391897 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75242452 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72303633 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70832006 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69471201 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66277855 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65752829 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61988206 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61606455 |
| 67 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61041624 |
| 68 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59335030 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58879933 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.57499886 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57473641 |
| 72 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55434145 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55384744 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54490280 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.53838800 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53465711 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50176810 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49699067 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48963832 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48937029 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48690861 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48435583 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47842320 |
| 84 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47230284 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46146963 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45801493 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45191352 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44740618 |
| 89 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44203600 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43932084 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.43926387 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.43830946 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.43669661 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42537862 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42382864 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40859070 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40319584 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.40239150 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40174588 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39196592 |
| 101 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38804527 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36503287 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35956485 |
| 104 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35151750 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35103487 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35046759 |
| 107 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33374627 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32844319 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32451740 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31544856 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.30628828 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27697610 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26954232 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26619370 |
| 115 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.26403207 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25769704 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24555241 |

